These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12556637)

  • 1. [Effectivity of phytotherapeutic agent prostavit for the treatment of benign prostate hyperplasia].
    Matjosaitis A; Radavicius A
    Medicina (Kaunas); 2002; 38 Suppl 1():59-62. PubMed ID: 12556637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors.
    Elterman DS; Lawrentschuk N; Guns E; Hersey K; Adomat H; Wood CA; Fleshner N
    J Urol; 2010 May; 183(5):2085-9. PubMed ID: 20303529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of phytotherapy on utility scores for 5 benign prostatic hyperplasia/lower urinary tract symptoms health states.
    Dedhia RC; Calhoun E; McVary KT
    J Urol; 2008 Jan; 179(1):220-5. PubMed ID: 18001791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study].
    Debruyne F; Koch G; Boyle P; Da Silva FC; Gillenwater JG; Hamdy FC; Perrin P; Teillac P; Vela-Navarrete R; Raynaud JP;
    Prog Urol; 2002 Jun; 12(3):384-92; discussion 394-4. PubMed ID: 12189744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of Cernilton on benign prostatic hyperplasia].
    Ueda K; Jinno H; Tsujimura S
    Hinyokika Kiyo; 1985 Jan; 31(1):187-91. PubMed ID: 2581428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytotherapeutic Agents for Benign Prostatic Hyperplasia: An Overview.
    Sharma M; Chadha R; Dhingra N
    Mini Rev Med Chem; 2017; 17(14):1346-1363. PubMed ID: 27337973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serenoa repens in benign prostatic hypertrophy: analysis of 2 Italian studies.
    Mantovani F
    Minerva Urol Nefrol; 2010 Dec; 62(4):335-40. PubMed ID: 20944533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phytotherapy for benign prostatic hyperplasia].
    Altarac S; Cindro V; Katusin D; Radović N
    Lijec Vjesn; 2010; 132(9-10):318-20. PubMed ID: 21261034
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of a phytotherapeutic agent, Eviprostat®, on prostatic and urinary cytokines/chemokines in a rat model of nonbacterial prostatitis.
    Sugimoto M; Oka M; Tsunemori H; Yamashita M; Kakehi Y
    Prostate; 2011 Mar; 71(4):438-44. PubMed ID: 21254154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Conservative treatment of benign prostatic hyperplasia].
    Romics I
    Orv Hetil; 2008 Oct; 149(40):1875-80. PubMed ID: 18815106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serenoa repens in benign prostatic hyperplasia].
    Log T
    Tidsskr Nor Laegeforen; 2008 May; 128(11):1293-4. PubMed ID: 18511974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using the planetary health framework to assess phytotherapeutic agents in the treatment of benign prostatic hyperplasia.
    Faure N
    Prog Urol; 2023 May; 33(6):285-286. PubMed ID: 36870915
    [No Abstract]   [Full Text] [Related]  

  • 13. Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men.
    Yokoyama O; Yoshida M; Kim SC; Wang CJ; Imaoka T; Morisaki Y; Viktrup L
    Int J Urol; 2013 Feb; 20(2):193-201. PubMed ID: 22958078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [With alpha blockers, finasteride and nettle root against benign prostatic hyperplasia. Which patients are helped by conservative therapy?].
    Vahlensieck W
    MMW Fortschr Med; 2002 Apr; 144(16):33-6. PubMed ID: 12043098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dutasteride improves objective and subjective disease measures in men with benign prostatic hyperplasia and modest or severe prostate enlargement.
    Gittelman M; Ramsdell J; Young J; McNicholas T
    J Urol; 2006 Sep; 176(3):1045-50; discussion 1050. PubMed ID: 16890688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What do we know about phytotherapy of benign prostatic hyperplasia?
    Allkanjari O; Vitalone A
    Life Sci; 2015 Apr; 126():42-56. PubMed ID: 25703069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.
    Debruyne F; Koch G; Boyle P; Da Silva FC; Gillenwater JG; Hamdy FC; Perrin P; Teillac P; Vela-Navarrete R; Raynaud JP
    Eur Urol; 2002 May; 41(5):497-506; discussion 506-7. PubMed ID: 12074791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid efficacy of the highly selective alpha1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies.
    Marks LS; Gittelman MC; Hill LA; Volinn W; Hoel G
    J Urol; 2009 Jun; 181(6):2634-40. PubMed ID: 19371887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia.
    Hizli F; Uygur MC
    Int Urol Nephrol; 2007; 39(3):879-86. PubMed ID: 17203353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Status of phytotherapeutic drugs in treatment of benign prostatic hyperplasia].
    Dreikorn K; Schönhöfer PS
    Urologe A; 1995 Mar; 34(2):119-29. PubMed ID: 7538709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.